Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-01 9:20 pm Purchase | 2025-04-29 | 13D | Corvus Pharmaceuticals, Inc. CRVS | ORBIMED ADVISORS LLC | 9,785,423 13.800% | 9,785,423 (New Position) | Filing History |
| 2025-04-25 7:48 pm Sale | 2025-04-22 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 332,500 10.700% | -37,743 (-10.19%) | Filing History |
| 2025-04-14 7:09 pm Unchanged | 2025-04-10 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-11 7:21 pm Purchase | 2024-04-09 | 13D | Compass Therapeutics, Inc. CMPX | ORBIMED ADVISORS LLC | 15,219,994 11.000% | 15,219,994 (New Position) | Filing History |
| 2025-03-12 7:57 pm Purchase | 2025-03-10 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 1,556,369 4.500% | 1,556,369 (New Position) | Filing History |
| 2025-02-14 4:35 pm Purchase | 2024-12-31 | 13G | ADC Therapeutics S.A. ADCT | ORBIMED ADVISORS LLC | 3,437,813 3.600% | 3,437,813 (New Position) | Filing History |
| 2025-02-14 4:32 pm Purchase | 2024-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | ORBIMED ADVISORS LLC | 1,641,908 9.900% | 1,641,908 (New Position) | Filing History |
| 2025-02-14 4:30 pm Purchase | 2024-12-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ORBIMED ADVISORS LLC | 718,200 5.900% | 718,200 (New Position) | Filing History |
| 2025-02-14 4:22 pm Purchase | 2024-12-31 | 13G | Forte Biosciences, Inc. FBRX | ORBIMED ADVISORS LLC | 510,000 8.000% | 510,000 (New Position) | Filing History |
| 2025-02-13 4:47 pm Purchase | 2025-02-10 | 13D | Sionna Therapeutics, Inc. SION | ORBIMED ADVISORS LLC | 3,704,959 8.400% | 3,704,959 (New Position) | Filing History |
| 2025-01-29 6:42 pm Purchase | 2024-12-31 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 760,824 19.900% | 760,824 (New Position) | Filing History |
| 2024-12-26 4:31 pm Purchase | 2024-12-20 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 370,243 12.000% | 370,243 (New Position) | Filing History |
| 2024-11-14 7:24 pm Unchanged | 2024-11-14 | 13G | Scholar Rock Holding Corporation SRRK | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 7:22 pm Unchanged | 2024-11-14 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 6:45 pm Unchanged | 2024-11-14 | 13G | Elevation Oncology, Inc. ELEV | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 6:43 pm Unchanged | 2024-11-14 | 13G | C4 Therapeutics, Inc. CCCC | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 6:41 pm Unchanged | 2024-11-14 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 6:35 pm Unchanged | 2024-11-14 | 13G | InspireMD, Inc. NSPR | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 6:30 pm Unchanged | 2024-11-14 | 13G | NeuroPace, Inc. NPCE | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 6:25 pm Unchanged | 2024-11-14 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |